Overall, PET−/plasma+ showed intermediate changes between PET−/plasma− and PET+/plasma+ in terms of tau burden, hippocampal and precuneus volume, cognitive function, cognitive decline, and genetic risk score. Here, MAPT is linked to Mental deterioration.